The muscle loss problem with GLP-1 therapy This is the conversation that does not get enough attention
This is essentially a glass cartridge filled with the drug solution, tucked inside a sleek, reusable plastic device roughly the size of a TV remote
Bloating and Constipation on GLP-1s Bloating and constipation are the two most common digestive complaints on GLP-1s, and they usually trace back to the same root cause: slower transit
Seino, Efficacy and safety of Tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE / and LDLr / mice by a mechanism that includes inflammatory pathways
They have not undergone the FDA's review for safety, effectiveness, or manufacturing quality as finished formulations - the review that every FDA-approved branded drug must pass